Quality Chemical Laboratories

About Quality Chemical Laboratories

Quality Chemical Laboratories (QCL) serves the pharmaceutical industry.  We provide expert and cGMP compliant scientific testing services in support of both small and large molecule drug products, drug substances, in-process materials, and raw materials in all phases of Research, Development, and Commercialization. QCL also provides formulation development and solid dose GMP manufacture supporting early phase clinical trials.Areas of expertise include:
Small and large molecule analytical development and validation, sample...

Certifications
  • US
  • 2019
    On CPHI since
  • 3
    Certificates
  • 250 - 499
    Employees
Company types
Biopharmaceutical company
CMO/CDMO
Contract Service
Manufacturer/Innovator
Pharmaceutical company
Primary activities
Analytical Services
Biopharmaceutical
Contract Manufacturer
Generic APIs producer
Laboratory Services
Pharmaceutical Company (generic finished products)
Pharmaceutical Company (innovator finished products)
Contact info
Meet us at

CPHI Americas 2025

Pennsylvania Convention Center, Philadelphia
20 May 2025 - 22 May 2025

Products from Quality Chemical Laboratories (1)

  • Analytical Testing and Formulation Development

    Product Analytical Testing and Formulation Development

    Quality Chemical Laboratories is known for its capabilities in the development and validation of analytical methods for raw materials, drug substances, and drug products. With a strong focus on quality and precision, QCL employs cutting-edge technologies and a highly skilled team of scientists to offer com...

Quality Chemical Laboratories Resources (1)

  • Whitepaper Rapid, Science-Driven Success in Early Phase Pharmaceutical Development

    THE CHALLENGE: Develop at least one dosage form that avoids first-pass metabolism in the gut and all analytical methods using a limited quantity API. THE STRATEGY: This program began with typical quality by design elements including excipient compatibility studies and API characterization allowing formulations development personnel to select the right excipients for initial prototype development. In fact, one excipient caused an API stability problem. Since the excipient compatibility study design was binary, the stability issue was easily isolated to a single excipient and eliminated from future formulation inclusion.